Kewaunee Scientific Co. (NASDAQ:KEQU) CEO Sells $126,020.00 in Stock

Kewaunee Scientific Co. (NASDAQ:KEQU) CEO Thomas David Hull III sold 2,000 shares of the company’s stock in a transaction that occurred on Thursday, December 26th. The shares were sold at an average price of $63.01, for a total value of $126,020.00. Following the sale, the chief executive officer now owns 42,497 shares in the company, valued at $2,677,735.97. The trade was a 4.49 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Kewaunee Scientific Stock Up 0.3 %

Shares of NASDAQ:KEQU opened at $63.81 on Monday. Kewaunee Scientific Co. has a 1-year low of $27.00 and a 1-year high of $66.15. The company’s fifty day moving average is $42.62 and its two-hundred day moving average is $43.31. The company has a debt-to-equity ratio of 0.48, a quick ratio of 2.00 and a current ratio of 2.53. The stock has a market capitalization of $183.26 million, a price-to-earnings ratio of 10.11 and a beta of 0.80.

Wall Street Analysts Forecast Growth

Separately, StockNews.com raised Kewaunee Scientific from a “hold” rating to a “buy” rating in a research report on Wednesday, December 18th.

Institutional Investors Weigh In On Kewaunee Scientific

Institutional investors and hedge funds have recently bought and sold shares of the business. Ritholtz Wealth Management bought a new position in shares of Kewaunee Scientific during the second quarter valued at approximately $413,000. Heron Bay Capital Management bought a new stake in shares of Kewaunee Scientific in the 2nd quarter worth approximately $252,000. Renaissance Technologies LLC boosted its position in Kewaunee Scientific by 13.4% during the 2nd quarter. Renaissance Technologies LLC now owns 89,611 shares of the technology company’s stock valued at $4,230,000 after purchasing an additional 10,580 shares during the period. De Lisle Partners LLP grew its stake in Kewaunee Scientific by 36.6% during the 3rd quarter. De Lisle Partners LLP now owns 42,958 shares of the technology company’s stock worth $1,446,000 after buying an additional 11,511 shares during the last quarter. Finally, Dimensional Fund Advisors LP increased its position in Kewaunee Scientific by 3.6% in the second quarter. Dimensional Fund Advisors LP now owns 177,548 shares of the technology company’s stock worth $8,378,000 after buying an additional 6,132 shares during the period. Institutional investors and hedge funds own 32.69% of the company’s stock.

Kewaunee Scientific Company Profile

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.